APA (7th ed.) Citation

G, L., AM, M., SL, C., & B, K. (2020). Review of Cerliponase Alfa: Recombinant Human Enzyme Replacement Therapy for Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2. Journal of child neurology, 35(5), 348. https://doi.org/10.1177/0883073819895694

Chicago Style (17th ed.) Citation

G, Lewis, Morrill AM, Conway-Allen SL, and Kim B. "Review of Cerliponase Alfa: Recombinant Human Enzyme Replacement Therapy for Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2." Journal of Child Neurology 35, no. 5 (2020): 348. https://doi.org/10.1177/0883073819895694.

MLA (9th ed.) Citation

G, Lewis, et al. "Review of Cerliponase Alfa: Recombinant Human Enzyme Replacement Therapy for Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2." Journal of Child Neurology, vol. 35, no. 5, 2020, p. 348, https://doi.org/10.1177/0883073819895694.